Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial Ischemia and reperfusion

Laura Calvillo, Emilio Vanoli, Elisa Andreoli, Alessandra Besana, Elisabetta Omodeo, Massimiliano Gnecchi, Pietro Zerbi, Gianluca Vago, Giuseppe Busca, Peter J. Schwartz

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Vagal activity has protective effects in ischemic heart disease. We tested whether vagal stimulation (VS) could modulate the inflammatory reaction, a major determinant of cardiac injury after ischemia/reperfusion. Four groups of male rats underwent myocardial ischemia (30 minutes) and reperfusion (24 hours). One group underwent VS (40 minutes), 1 VS plus atrial pacing (VS + Pacing), and 1 VS plus nicotinic inhibition by mecamylamine (VS + MEC). After 24 hours, the area at risk, infarct size, inflammation parameters, and apoptosis were quantified. Infarct size was reduced in all VS-treated rats (controls, 53 ± 18%; VS, 6.5 ± 3%; VS + Pacing, 23 ± 6%; VS + MEC, 33 ± 9%; P <0.005 vs. controls). The infarct size in the VS + MEC group was larger than that in VS-treated animals, despite similar heart rate, suggesting partial loss of protection. The number of macrophages, neutrophils, and apoptotic cells in the area at risk and the plasma cytokines levels were significantly reduced in all VS-treated animals. In conclusion, VS decreases infarct size and inflammatory markers during ischemia/reperfusion independent of the heart rate. The anti-inflammatory and antiapoptotic properties of the nicotinic pathway are the primary underlying mechanism. The vagally mediated modulation of inflammatory responses may prove valuable in the clinical management of acute coronary syndromes and of heart failure.

Original languageEnglish
Pages (from-to)500-507
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume58
Issue number5
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Myocardial Reperfusion
Reperfusion
Myocardial Ischemia
Heart Rate
Mecamylamine
Acute Coronary Syndrome
Reperfusion Injury
Neutrophils
Anti-Inflammatory Agents
Ischemia
Heart Failure
Macrophages
Apoptosis
Cytokines
Inflammation

Keywords

  • autonomic nervous system
  • infarct size
  • inflammatory markers
  • ischemia/reperfusion
  • myocardial infarction
  • vagal activity

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial Ischemia and reperfusion. / Calvillo, Laura; Vanoli, Emilio; Andreoli, Elisa; Besana, Alessandra; Omodeo, Elisabetta; Gnecchi, Massimiliano; Zerbi, Pietro; Vago, Gianluca; Busca, Giuseppe; Schwartz, Peter J.

In: Journal of Cardiovascular Pharmacology, Vol. 58, No. 5, 11.2011, p. 500-507.

Research output: Contribution to journalArticle

@article{1253d1abafec48beb76580ba66cdae2f,
title = "Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial Ischemia and reperfusion",
abstract = "Vagal activity has protective effects in ischemic heart disease. We tested whether vagal stimulation (VS) could modulate the inflammatory reaction, a major determinant of cardiac injury after ischemia/reperfusion. Four groups of male rats underwent myocardial ischemia (30 minutes) and reperfusion (24 hours). One group underwent VS (40 minutes), 1 VS plus atrial pacing (VS + Pacing), and 1 VS plus nicotinic inhibition by mecamylamine (VS + MEC). After 24 hours, the area at risk, infarct size, inflammation parameters, and apoptosis were quantified. Infarct size was reduced in all VS-treated rats (controls, 53 ± 18{\%}; VS, 6.5 ± 3{\%}; VS + Pacing, 23 ± 6{\%}; VS + MEC, 33 ± 9{\%}; P <0.005 vs. controls). The infarct size in the VS + MEC group was larger than that in VS-treated animals, despite similar heart rate, suggesting partial loss of protection. The number of macrophages, neutrophils, and apoptotic cells in the area at risk and the plasma cytokines levels were significantly reduced in all VS-treated animals. In conclusion, VS decreases infarct size and inflammatory markers during ischemia/reperfusion independent of the heart rate. The anti-inflammatory and antiapoptotic properties of the nicotinic pathway are the primary underlying mechanism. The vagally mediated modulation of inflammatory responses may prove valuable in the clinical management of acute coronary syndromes and of heart failure.",
keywords = "autonomic nervous system, infarct size, inflammatory markers, ischemia/reperfusion, myocardial infarction, vagal activity",
author = "Laura Calvillo and Emilio Vanoli and Elisa Andreoli and Alessandra Besana and Elisabetta Omodeo and Massimiliano Gnecchi and Pietro Zerbi and Gianluca Vago and Giuseppe Busca and Schwartz, {Peter J.}",
year = "2011",
month = "11",
doi = "10.1097/FJC.0b013e31822b7204",
language = "English",
volume = "58",
pages = "500--507",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial Ischemia and reperfusion

AU - Calvillo, Laura

AU - Vanoli, Emilio

AU - Andreoli, Elisa

AU - Besana, Alessandra

AU - Omodeo, Elisabetta

AU - Gnecchi, Massimiliano

AU - Zerbi, Pietro

AU - Vago, Gianluca

AU - Busca, Giuseppe

AU - Schwartz, Peter J.

PY - 2011/11

Y1 - 2011/11

N2 - Vagal activity has protective effects in ischemic heart disease. We tested whether vagal stimulation (VS) could modulate the inflammatory reaction, a major determinant of cardiac injury after ischemia/reperfusion. Four groups of male rats underwent myocardial ischemia (30 minutes) and reperfusion (24 hours). One group underwent VS (40 minutes), 1 VS plus atrial pacing (VS + Pacing), and 1 VS plus nicotinic inhibition by mecamylamine (VS + MEC). After 24 hours, the area at risk, infarct size, inflammation parameters, and apoptosis were quantified. Infarct size was reduced in all VS-treated rats (controls, 53 ± 18%; VS, 6.5 ± 3%; VS + Pacing, 23 ± 6%; VS + MEC, 33 ± 9%; P <0.005 vs. controls). The infarct size in the VS + MEC group was larger than that in VS-treated animals, despite similar heart rate, suggesting partial loss of protection. The number of macrophages, neutrophils, and apoptotic cells in the area at risk and the plasma cytokines levels were significantly reduced in all VS-treated animals. In conclusion, VS decreases infarct size and inflammatory markers during ischemia/reperfusion independent of the heart rate. The anti-inflammatory and antiapoptotic properties of the nicotinic pathway are the primary underlying mechanism. The vagally mediated modulation of inflammatory responses may prove valuable in the clinical management of acute coronary syndromes and of heart failure.

AB - Vagal activity has protective effects in ischemic heart disease. We tested whether vagal stimulation (VS) could modulate the inflammatory reaction, a major determinant of cardiac injury after ischemia/reperfusion. Four groups of male rats underwent myocardial ischemia (30 minutes) and reperfusion (24 hours). One group underwent VS (40 minutes), 1 VS plus atrial pacing (VS + Pacing), and 1 VS plus nicotinic inhibition by mecamylamine (VS + MEC). After 24 hours, the area at risk, infarct size, inflammation parameters, and apoptosis were quantified. Infarct size was reduced in all VS-treated rats (controls, 53 ± 18%; VS, 6.5 ± 3%; VS + Pacing, 23 ± 6%; VS + MEC, 33 ± 9%; P <0.005 vs. controls). The infarct size in the VS + MEC group was larger than that in VS-treated animals, despite similar heart rate, suggesting partial loss of protection. The number of macrophages, neutrophils, and apoptotic cells in the area at risk and the plasma cytokines levels were significantly reduced in all VS-treated animals. In conclusion, VS decreases infarct size and inflammatory markers during ischemia/reperfusion independent of the heart rate. The anti-inflammatory and antiapoptotic properties of the nicotinic pathway are the primary underlying mechanism. The vagally mediated modulation of inflammatory responses may prove valuable in the clinical management of acute coronary syndromes and of heart failure.

KW - autonomic nervous system

KW - infarct size

KW - inflammatory markers

KW - ischemia/reperfusion

KW - myocardial infarction

KW - vagal activity

UR - http://www.scopus.com/inward/record.url?scp=80955144444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955144444&partnerID=8YFLogxK

U2 - 10.1097/FJC.0b013e31822b7204

DO - 10.1097/FJC.0b013e31822b7204

M3 - Article

C2 - 21765369

AN - SCOPUS:80955144444

VL - 58

SP - 500

EP - 507

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -